Monday, 15 October 2018

Stephen Lacey' s stories

Sort by: Newest firstOldest firstA-ZZ-A

  • Lithium IPOs short-circuited by oversupply

    Equities | 12 October 2018

    Lithium, the silvery-white akali metal crucial to the electric vehicle revolution, is all the rage of the capital markets.

  • An employee displays cannabis buds in a posed photo at Hexo Corp's facilities in Gatineau, Quebec, Canada,

    Tilray smokes out US$450m from five-year CB

    Top News | 05 October 2018

    Less than three months after going public, cannabis grower Tilray landed US$450m from the sale of an upsized five-year convertible bond to fuel its budding expansion.

  • FMC charges ahead with lithium spin-off

    Equities | 05 October 2018

    With no lack of news out of the electric vehicle industry, FMC Corp hit the road this week with the long-awaited spin-off IPO of its lithium business, Livent.

  • hemp cannabis

    Tilray bakes CB into sky-high valuation

    Ticker | 04 October 2018

    Well that didn’t take long. Less than three months after going public, Tilray  is looking to a US$400m, five-year CB to fuel its budding expansion and take advantage of its soaring share price, which is up 800% since the IPO.

  • A visitor looks through a microscope at a laboratory in a pharmaceutical manufacturing factory in Singapore.

    Biotechs rush to fund ahead of midterms

    Top News | 28 September 2018

    US biotech companies are on track to break records for annual equity fundraising as they move from private to public markets with increased speed. The steady climb of the NYSE biotech index over the past two years has made ECM transactions easier, though the strong support of existing shareholders has delivered momentum and scarcity to IPOs.

  • CenterPoint digests US$2.5bn of equity for M&A

    Equities | 28 September 2018

    CenterPoint Energy, the Texan regulated utility, bit the bullet on securing the US$6bn of cash needed to fund the acquisition of Vectren with a US$2.5bn, two-part equity-linked raise Wednesday.

  • Biotech IPOs hit the wall

    Equities | 28 September 2018

    Fissures are opening in the biotech new issue market.

  • Natural gas pipeline

    CenterPoint undertakes balancing act on M&A funding

    Ticker | 25 September 2018

    CenterPoint Energy, the Texan regulated utility, is pushing ahead with a two-part US$2.25bn equity-linked raise to help fund the US$6bn cash cost of its purchase of Indiana-based natural gas utility Vectren.

  • Elanco Animal Health

    Elanco proves to be investors' best friend

    Top News | 21 September 2018

    Elanco Animal Health, Eli Lilly’s animal health unit, exploded onto public markets, achieving above-target pricing on its spin-off IPO and surging 50% on debut.

  • Zekelman refuses to negotiate on IPO

    Equities | 21 September 2018

    Zekelman Industries, a family-owned maker of industrial steel pipes, pulled the plug on its IPO last Tuesday morning, three full days ahead of planned pricing.

Show  10 per page20 per page50 per page